Stock market week-in-review for 5 large GI companies — Aug. 28-Sept. 1

Here is how five major, publicly traded gastroenterology companies fared in the stock market for the week of Aug. 28 to Sept. 1, 2017.

Advertisement

Note: This data was compiled using Google Finance.

1. Allergan Pharmaceuticals

Opened: $222.13 on Aug. 28
Peaked: $231.22 on Sept. 1
Closed: $227.70 on Sept. 1
Percent change between Aug 28 to Sept. 1: 2.5 percent

2. Exact Sciences Corp.

Opened: $40.49 on Aug. 28
Peaked: $41.99 on Aug. 31
Closed: $41.61 on Sept. 1
Percent change between Aug 28 to Sept. 1: 2.76 percent

3. Johnson & Johnson

Opened: $131.73 on Aug. 28
Peaked: $132.58 on Sept. 1
Closed: $131.01 on Sept. 1
Percent change between Aug 28 to Sept. 1: -0.54 percent

4. Synergy Pharmaceuticals

Opened: $3.12 on Aug. 28
Peaked at open
Closed: $3.01 on Sept. 1
Percent change between Aug 28 to Sept. 1: -3.52 percent

5. Valeant Pharmaceuticals

Opened: $14.03 on Aug. 28
Peaked: $14.26 on Aug. 28
Closed: $13.32 on Sept. 1
Percent change between Aug 28 to Sept. 1: -5.06 percent

More articles on gastroenterology:
What 15 healthcare practices pay their gastroenterologists — $458k is #1
Gastroenterologists, payers possibly thwarting biosimilar adaptation — 4 key notes
‘Relentless dedication to IBD care’ — How 3 GI leaders will use their Sherman Prizes to enhance IBD, Crohn’s treatment

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.